PHARMA-BIO SERV, INC. Marketable Securities, Gain (Loss)
PHARMA-BIO SERV, INC. (PBSV) reported Marketable Securities, Gain (Loss) of $8.20 million for the 3-month period ending 2023-01-31, per its 10-Q filed 2023-03-17.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2023-03-17
- PHARMA-BIO SERV, INC. marketable securities, gain (loss) for the quarter ending 2023-01-31 was $8.20M.
- PHARMA-BIO SERV, INC. marketable securities, gain (loss) for the quarter ending 2022-01-31 was $0.00.
| Period end | Marketable Securities, Gain (Loss) 3 month |
|---|---|
| 2023-01-31 | $8.20M 10-Q · filed 2023-03-17 |
| 2022-01-31 | $0.00 10-Q · filed 2023-03-17 |